Avicanna (AVCNF) Stock Price, Quote, News & History

Avicanna Inc (AVCNF) Stock Price, Quote, News & History

AVCNFOTCQX

Trade with Public

$0.1383

-0.0001-0.07%

At close: Mar 12, 5:00 PM EST

Key Statistics

Open

$0.14

Volume / Avg.

5.00K / 43.14K

Day Range

$0.14 - $0.14

52 Wk Range

0.11 - 0.27

Market Cap

$17.36M

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

1.52

Recent Avicanna Inc News

World's Largest Tobacco Company Is Investing In Medical Cannabis: Here's What To Know

Philip Morris is expanding its medical cannabis strategy via Aurora and Avicanna. What it means for the future of Big Tobacco in the cannabinoid space.

Javier Hasse

This Week In Cannabis: Carmelo's NY Launch, Federal Reform, Cancer Study, Avicanna's Growth, Tilray's Split, DeSantis Fallout, Slovenia's Big Move And More

Cannabis news this week: Congress revives cannabis reform, Slovenia leads Europe, Tyson takes charge and science backs cannabis for cancer care.

Javier Hasse

Why Cannabis-Focused Biopharma Co. Avicanna Traded Up 26%+ Today

Shares of Avicanna Inc.

Javier Hasse

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-1.23M

Investing Cash Flow (TTM)

-554.06K

Financing Cash Flow (TTM)

1.63M

Free Cash Flow (TTM)

-1.79M

Capital Expenditure (TTM)

-555.13K

Net Change in Cash (TTM)

-156.09K

Valuation Metrics

Enterprise Value

$16.51M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

0.83

PB Ratio (TTM)

7.59

Earnings Yield % (TTM)

-3.28%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

$0.02

Company Debt

Total Debt

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

-$249.09K

Total Cash

$464.85K

Debt to Equity

0.00

Issuance of Debt (TTM)

-$249.09K

Repayment of Debt (TTM)

-$249.09K

Key Statistics

Open

$0.14

Volume / Avg.

5.00K / 43.14K

Day Range

$0.14 - $0.14

52 Wk Range

0.11 - 0.27

Market Cap

$17.36M

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

1.52

About

Sector

Health Care

Industry

Pharmaceuticals

Avicanna Inc is a commercial-stage international biopharmaceutical company focused on the development, advancement, and commercialization of evidence-based cannabinoid-based products and formulations for the medical and pharmaceutical market segments...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Avicanna (AVCNF) stock?

You can purchase shares of Avicanna (OTCQX:AVCNF) through any online brokerage.

View our list of the best stock brokerages

Who are Avicanna (AVCNF) competitors?

There are no as such competitors for Avicanna.

What is the forecast, or price target, for Avicanna (AVCNF) stock?

There is no analysis for Avicanna to provide a consensus price target.

What is the current price for Avicanna (AVCNF)?

The stock price for Avicanna (OTCQX: AVCNF) is $0.1383 last updated March 12, 2026 at 9:44 AM EDT.

Does Avicanna (AVCNF) pay a dividend?

There are no upcoming dividends for Avicanna.

When is Avicanna (OTCQX:AVCNF) reporting earnings?

Avicanna does not have any upcoming earnings scheduled.

Is Avicanna (AVCNF) going to split?

There is no upcoming split for Avicanna.

What sector and industry does Avicanna (AVCNF) operate in?

Avicanna is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCQX.

Key Statistics

Open

$0.14

Volume / Avg.

5.00K / 43.14K

Day Range

$0.14 - $0.14

52 Wk Range

0.11 - 0.27

Market Cap

$17.36M

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

1.52

Recent Avicanna Inc News

World's Largest Tobacco Company Is Investing In Medical Cannabis: Here's What To Know

Philip Morris is expanding its medical cannabis strategy via Aurora and Avicanna. What it means for the future of Big Tobacco in the cannabinoid space.

Javier Hasse

This Week In Cannabis: Carmelo's NY Launch, Federal Reform, Cancer Study, Avicanna's Growth, Tilray's Split, DeSantis Fallout, Slovenia's Big Move And More

Cannabis news this week: Congress revives cannabis reform, Slovenia leads Europe, Tyson takes charge and science backs cannabis for cancer care.

Javier Hasse

Why Cannabis-Focused Biopharma Co. Avicanna Traded Up 26%+ Today

Shares of Avicanna Inc.

Javier Hasse